{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:30:56Z","timestamp":1791045056343,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.contraception.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T15:14:21Z","timestamp":1615043661000},"page":"386-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function"],"prefix":"10.1016","volume":"103","author":[{"given":"Ingrid","family":"Duijkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-0063","authenticated-orcid":false,"given":"Christine","family":"Klipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Kinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-3573","authenticated-orcid":false,"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2021.03.003_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Electronic address Aao, Practice Committee of the American Society for Reproductive M. Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2021.03.003_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0003","first-page":"40","article-title":"Cardiovascular safety in users of different combined oral contraceptives \u2013 Final results from the INAS-SCORE study","volume":"23","author":"Heinemann","year":"2018","journal-title":"Abstract FC-03 Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.03.003_bib0004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.03.003_bib0005","first-page":"207","article-title":"Metabolism of 17-beta-oestradiol-4-14-C in early infancy","volume":"49","author":"Hagen","year":"1965","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2021.03.003_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13697130802050340","article-title":"In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism","volume":"11","author":"Visser","year":"2008","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2021.03.003_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2021.03.003_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2008.12.013","article-title":"Clinical applications for estetrol","volume":"114","author":"Visser","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2021.03.003_bib0009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13697130802054078","article-title":"A new route of synthesis of estetrol","volume":"11","author":"Warmerdam","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2021.03.003_bib0010","first-page":"476","article-title":"Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.03.003_bib0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.contraception.2016.04.015","article-title":"Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)","volume":"94","author":"Apter","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0012","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13625187.2017.1336532","article-title":"Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control","volume":"22","author":"Apter","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.03.003_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.003_bib0014","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/humrep\/deh494","article-title":"Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle","volume":"19","author":"Duijkers","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2021.03.003_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0010-7824(80)90142-0","article-title":"Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration","volume":"21","author":"Landgren","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0016","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1783\/147118908786000451","article-title":"Ovulation incidence with oral contraceptives: a literature review","volume":"34","author":"Milsom","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.03.003_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9378(98)70249-2","article-title":"Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation","volume":"179","author":"Elomaa","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.003_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0020","series-title":"Estetrol 15 mg combined with drospirenone 3 mg is an effective oral contraceptive: results from the E4Freedom EU\/RU phase 3 trial. Abstract 9027, 13th Congress European Society of Gynecology. Vienna, Austria, October 16-19","author":"Creinin","year":"2019"},{"key":"10.1016\/j.contraception.2021.03.003_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.contraception.2020.07.063","article-title":"Phase 3 Clinical trial results of a new combined oral contraceptive with Estetrol 15 mg and Drospirenone 3 mg","volume":"102","author":"Creinin","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.003_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:18:20Z","timestamp":1757881100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0010782421000585"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.03.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}